2024-02-29
ENA first public
ERC000011
ENA-CHECKLIST
Wellcome Sanger Institute
INSDC center name
public
INSDC status
ERS18373722
SRA accession
E-MTAB-12720_2:T23_TNF_wk7_CITEseq
Submitter Id
ArrayExpress
broker name
HPSI0114i-kolf_2
cell_line
human induced pluripotent stem cells
cell_type
not collected
collection date
human
common name
Protocols: For dissociation of organoids on day −7, they were removed from culture insert and incubated in digestion buffer, which consisted of collagenase type IV solution (StemCell Technologies) supplemented with 0.88mg/ml collagenase/dispase (Roche) and 50U DNase I (Sigma), for 20 minutes at 37oC. Vigorous pipetting was performed in the middle of the incubation and at the end. After complete disaggregation, single cell suspension was prepared by passing through a 50-μm strainer.  For dissociation of organoids from day 0 onwards, a cell scraper was used to detach ATOs from cell culture insert membranes and detached ATOs were then submerged in cold flow buffer (PBS (Gibco) containing 2% (v/v) fetal bovine serum (FBS; Gibco) and 2 mM EDTA (Invitrogen)). Culture inserts were washed and detached ATOs were pipetted up and down to form single-cell suspension before passing through a 50-μm strainer.   Cells were then stained with designed panels of antibodies and analyzed by flow cytometry. FACS was performed at the same time and live human DAPI–anti-mouse CD29– (APC/Cy7 anti-mouse CD29 antibody, Biolegend, 102225) cells were sorted for day −7, day 0 and week 3 samples, and live (DAPI–) cells were sorted for week 5 and week 7 samples before loading onto each channel of the Chromium chip from Chromium single cell V(D)J kit (10X Genomics). The metadata for all the ATO samples can be found in ATO_manifest.csv. For the day −14 sample, some sorted (both hEMP and the rest of DAPI– fraction) and unsorted cells were stained with hashtag antibodies (TotoalSeq-C antibodies from Biolegend, see ATO_hashtagging.csv, following 10X cell surface protein labeling protocol) before being mixed together with some mouse stromal cells (MS5-hDLL4) for 10X loading. For week 1 sample, hashtag antibodies were added in at the same time as the FACS antibodies i.e. before sorting.  We followed the PSC-ATO protocol as previously described30. iPSC cells were harvested as a single-cell suspension and seeded (3×106 cells per well) in GFR reduced Matrigel (Corning) - coated 6-well plates in X-VIVO 15 media (Lonza), supplemented with rhActivin A, rhBMP4, rhVEGF, rhFGF (all from R&D Systems), and ROCK inhibitor (Y27632; LKT Labs) on day −17, and only rhBMP4, rhVEGF and rhFGF on days −16 and −15. Cells were harvested 3.5 days later (day−14) , and isolated by FACS for CD326–CD56+ (PE anti-human CD326 antibody, Biolegend, 324205; APC anti-human CD56 antibody, Biolegend, 318309) human embryonic mesodermal progenitors (hEMPs).  Isolated hEMPs were combined with MS5-hDLL4 at a ratio of 1:50. Two or three cell-dense droplets (5×105 cells in 6 μl hematopoietic induction medium) were deposited on top of an insert in each well of a six-well plate. Hematopoietic induction medium composed of EGM2 (Lonza) supplemented with ROCK inhibitor and SB blocker (TGF-β receptor kinase inhibitor SB- 431542; Abcam) was added into the wells outside the inserts so that the cells sat at the air-liquid interface. The organoids were then cultured in EGM2 with SB blocker for 7 days (days −14 to −7), before the addition of cytokines rhSCF, rhFLT3L, rhTPO (all from Peprotech) between days −6 to 0. These 2 weeks formed the hematopoietic induction phase. On day 1, media was changed again to RB27 (RPMI supplemented with B27 (Gibco), ascorbic acid (Sigma-Aldrich), penicillin/streptomycin (Sigma-Aldrich) and glutamax (Thermo Fisher Scientific)) with rhSCF, rhFLT3L and rhIL7. The organoids can be maintained in culture for 7 more weeks in this medium.  For the TNFɑ validation experiment, we followed the PSC-ATO protocol described previously using Kolf iPSC line. One plate (12 organoids) was set for each condition, with 4 conditions which were 1) control i.e., no TNFɑ addition, 2) 1 ng/ml TNFɑ (final  concentration), 3) 5 ng/ml TNFɑ, and 4) 25 ng/ml TNFɑ. TNFɑ was added into the media between week 6 to 7. Organoids were harvested at week 7, stained with hashtag antibodies (TotalSeq-C antibodies from Biolegend) and a designed panel of FACS antibodies, and sorted for CD45+ cells before 10X loading.  Single-cell cDNA synthesis, amplification and gene expression (GEX) and cell surface protein (CITE-seq) libraries were generated following the manufacturer’s instructions.  Single-cell cDNA synthesis, amplification and gene expression (GEX) and cell surface protein (CITE-seq) libraries were generated following the manufacturer’s instructions.
description
not collected
geographic location (country and/or sea)
growth condition
not applicable
isolate
Homo sapiens
organism
Homo sapiens
organism
Homo sapiens
scientific_name
T23_TNF_wk7_CITEseq
title